January 16, 2018 / 9:26 AM / a year ago

BRIEF-Shandong Xinhua Pharmaceutical Sees Rise In FY Profit Attributable

Jan 16 (Reuters) - Shandong Xinhua Pharmaceutical Co Ltd :

* EXPECTED TO RECORD RISE IN NET PROFIT ATTRIBUTABLE TO SHAREHOLDERS DURING 2017

* SEES FY PROFIT ATTRIBUTABLE IN RANGE RMB 184 MILLION TO RMB 244 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below